|
1BY3
FHUA FROM E. COLI
Deposited 1998-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–747(714 aa)
|
Not recorded
|
OES N-OCTYL-2-HYDROXYETHYL SULFOXIDE × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.2;PROTEIN WAS CRYSTALLIZED FROM 33% PEG2000, 0.45 M NACL, 0.15 M NAPI (PH 6.2)
AND 0.5% N-OCTYL-2-HYDROXYETHYLSULFOXIDE
|
Resolution 2.74 Å
R-free 0.244
|
|
1FCP
FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) FROM E.COLI IN COMPLEX WITH BOUND FERRICHROME-IRON
Deposited 1998-10-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
52–747(696 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
NI NICKEL (II) ION × 2
LIL 2-TRIDECANOYLOXY-PENTADECANOIC ACID × 2
AAE ACETOACETIC ACID × 1
LIM 3-OXO-PENTADECANOIC ACID × 1
EA2 AMINOETHANOLPYROPHOSPHATE × 1
FCI FERRICROCIN-IRON × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.4;100MM NA-CACODYLATE, PH 6.4, 12.5% PEG2000 MME, 20% GLYCEROL, 3% PEG200
|
Resolution 2.70 Å
R-free 0.281
|
|
1FI1
FhuA in complex with lipopolysaccharide and rifamycin CGP4832
Deposited 2000-08-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
52–747(696 aa)
|
Mutation:HEXAHISTIDINE TAG PLUS FIVE LINKER RESIDUES HAVE BEEN GENETICALLY INSERTED AFTER RESIDUE 405 OF THE MATURE SEQUENCE
|
FTT 3-HYDROXY-TETRADECANOIC ACID × 6
PO4 PHOSPHATE ION × 2
NI NICKEL (II) ION × 1
NA SODIUM ION × 1
MG MAGNESIUM ION × 1
DPO DIPHOSPHATE × 2
RIF RIFAMYCIN CGP 4832 × 1
DDQ DECYLAMINE-N,N-DIMETHYL-N-OXIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;291 K;100 mM sodium cacodylate, 12% PEG 2,000 MME, 3% PEG 200, 1% cis-inositol, 20% glycerol, 1 mM rifamycin CGP 4832, pH 6.4, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.90 Å
R-free 0.275
|
|
1QFF
E. COLI FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) IN COMPLEX WITH BOUND FERRICHROME-IRON
Deposited 1999-04-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–747(714 aa)
|
Mutation:SER-SER-HIS-HIS-HIS-HIS-HIS-HIS-GLY-SER-SER AFFINITY TAG
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PO4 PHOSPHATE ION × 2
FTT 3-HYDROXY-TETRADECANOIC ACID × 4
DAO LAURIC ACID × 1
MYR MYRISTIC ACID × 1
DPO DIPHOSPHATE × 1
EAP 2-AMINO-VINYL-PHOSPHATE × 1
FCI FERRICROCIN-IRON × 1
DDQ DECYLAMINE-N,N-DIMETHYL-N-OXIDE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.4;pH 6.4
|
Resolution 2.70 Å
R-free 0.276
|
|
1QFG
E. COLI FERRIC HYDROXAMATE RECEPTOR (FHUA)
Deposited 1999-04-10
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–747(714 aa)
|
Mutation:YES
|
NI NICKEL (II) ION × 1
PO4 PHOSPHATE ION × 2
FTT 3-HYDROXY-TETRADECANOIC ACID × 4
DAO LAURIC ACID × 1
MYR MYRISTIC ACID × 1
DDQ DECYLAMINE-N,N-DIMETHYL-N-OXIDE × 3
DPO DIPHOSPHATE × 2
GOL GLYCEROL × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.4;290 K;100MM SODIUM CACODYLATE (PH 6.4), 12.5% PEG 2000 MONOMETHYLETHER, 20% GLYCEROL,
1% CIS-INOSITOL, 3% PEG 200, VAPOR DIFFUSION, HANGING DROP, temperature 290K
|
Resolution 2.50 Å
R-free 0.271
|
|
1QJQ
FERRIC HYDROXAMATE RECEPTOR FROM ESCHERICHIA COLI (FHUA)
Deposited 1999-06-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–438(405 aa)
Chain A
439–747(309 aa)
|
Mutation:YES
Mutation:YES
|
FTT 3-HYDROXY-TETRADECANOIC ACID × 6
DPO DIPHOSPHATE × 2
PO4 PHOSPHATE ION × 2
NI NICKEL (II) ION × 1
PFC PHENYLFERRICROCIN-IRON × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.4;100MM SODIUM CACODYLATE (PH 6.4), 14.5% PEG 2000 MONOMETHYLETHER, 20% GLYCEROL, 3% PEG 200, 1 MM PHENYLFERRICROCIN-IRON
|
Resolution 2.95 Å
R-free 0.278
|
|
1QKC
ESCHERICHIA COLI FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) IN COMPLEX DELTA TWO-ALBOMYCIN
Deposited 1999-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–438(405 aa)
Chain A
439–747(309 aa)
|
Mutation:YES
Mutation:YES
|
FTT 3-HYDROXY-TETRADECANOIC ACID × 6
DPO DIPHOSPHATE × 2
PO4 PHOSPHATE ION × 2
NI NICKEL (II) ION × 1
ALB DELTA-2-ALBOMYCIN A1 × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.4;100 MM SODIUM CACODYLATE (PH 6.4), 14.0% POLYETHYLGLYCOL 2000 MONOMETHYLETHER, 20% GLYCEROL, 3% POLYETHYLGLYCOL 200, 1% CIS-INOSITOL, 0.3 MM DELTA TWO ALBOMYCIN
|
Resolution 3.10 Å
R-free 0.283
|
|
2FCP
FERRIC HYDROXAMATE UPTAKE RECEPTOR (FHUA) FROM E.COLI
Deposited 1998-10-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
34–747(714 aa)
|
Not recorded
|
NI NICKEL (II) ION × 2
LIL 2-TRIDECANOYLOXY-PENTADECANOIC ACID × 2
AAE ACETOACETIC ACID × 1
LIM 3-OXO-PENTADECANOIC ACID × 1
EA2 AMINOETHANOLPYROPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.4;100MM NA-CACODYLATE, PH 6.4, 12.5% PEG2000 MME, 20% GLYCEROL, 1% CIS-INOSITOL, 3% PEG200
|
Resolution 2.50 Å
R-free 0.283
|
|
2GRX
Crystal structure of TonB in complex with FhuA, E. coli outer membrane receptor for ferrichrome
Deposited 2006-04-25
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
34–758(725 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
FTT 3-HYDROXY-TETRADECANOIC ACID × 4
DPO DIPHOSPHATE × 1
DAO LAURIC ACID × 1
EAP 2-AMINO-VINYL-PHOSPHATE × 1
FCI FERRICROCIN-IRON × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;291 K;8% polyethylene glycol 4000, 50 mM MES (pH 6.0), 75 mM NaCl, 5% glycerol, 0.7% C8E4, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 3.30 Å
R-free 0.329
|
|
2GRX
Crystal structure of TonB in complex with FhuA, E. coli outer membrane receptor for ferrichrome
Deposited 2006-04-25
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
34–758(725 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
FTT 3-HYDROXY-TETRADECANOIC ACID × 4
DPO DIPHOSPHATE × 1
DAO LAURIC ACID × 1
EAP 2-AMINO-VINYL-PHOSPHATE × 1
FCI FERRICROCIN-IRON × 1
MYR MYRISTIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;291 K;8% polyethylene glycol 4000, 50 mM MES (pH 6.0), 75 mM NaCl, 5% glycerol, 0.7% C8E4, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 3.30 Å
R-free 0.329
|
|
8A60
Crystal structure of FhuA in complex with the superinfection exclusion lipoprotein Llp
Deposited 2022-06-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
34–747(714 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;293 K;12-16% PEG 4000
0.4 M sodium isothiocyanate
0.1 M sodium acetate
|
Resolution 3.37 Å
R-free 0.307
|
|
8A8C
T5 phage receptor-binding protein pb5 bound to ferrichrome transporter FhuA
Deposited 2022-06-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
34–747(714 aa)
|
Not recorded
|
LU9 [(2R,3S,4R,5R,6R)-2-[[(2R,4R,5R,6R)-6-[(1R)-1,2-bis(oxidanyl)ethyl]-4-[(2R,4R,5R,6R)-6-[(1R)-1,2-bis(oxidanyl)ethyl]-2-carboxy-4,5-bis(oxidanyl)oxan-2-yl]oxy-2-carboxy-5-oxidanyl-oxan-2-yl]oxymethyl]-5-[[(3R)-3-dodecanoyloxytetradecanoyl]amino]-4-(3-nonanoyloxypropanoyloxy)-6-[[(2R,3S,4R,5R,6R)-3-oxidanyl-4-[(3S)-3-oxidanyltetradecanoyl]oxy-5-[[(3R)-3-oxidanyltridecanoyl]amino]-6-phosphonatooxy-oxan-2-yl]methoxy]oxan-3-yl] phosphate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
8B14
T5 Receptor Binding Protein pb5 in complex with its E. coli receptor FhuA
Deposited 2022-09-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
34–747(714 aa)
|
Mutation:Presence of an Histag after P405, added residues : SHHHHHHGS
|
DDQ DECYLAMINE-N,N-DIMETHYL-N-OXIDE × 1
LU9 [(2R,3S,4R,5R,6R)-2-[[(2R,4R,5R,6R)-6-[(1R)-1,2-bis(oxidanyl)ethyl]-4-[(2R,4R,5R,6R)-6-[(1R)-1,2-bis(oxidanyl)ethyl]-2-carboxy-4,5-bis(oxidanyl)oxan-2-yl]oxy-2-carboxy-5-oxidanyl-oxan-2-yl]oxymethyl]-5-[[(3R)-3-dodecanoyloxytetradecanoyl]amino]-4-(3-nonanoyloxypropanoyloxy)-6-[[(2R,3S,4R,5R,6R)-3-oxidanyl-4-[(3S)-3-oxidanyltetradecanoyl]oxy-5-[[(3R)-3-oxidanyltridecanoyl]amino]-6-phosphonatooxy-oxan-2-yl]methoxy]oxan-3-yl] phosphate × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8.5
cryo-EM vitrification conditions
Cryogen ETHANE;3.5 microliters of the FhuA-pb5 complex were deposited on a freshly glow discharged (25 mA, 30 sec) Cu/Rh 400 mesh Quantifoil R 2/1 EM grids and flash-frozen in nitrogen-cooled liquid ethane using a ThermoFisher Mark IV Vitrobot device (100% humidity, 293.15K, 2s blotting time, blot force 1).
|
Resolution 2.60 Å
|